BI 1819479 / Boehringer Ingelheim  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BI 1819479 / Boehringer Ingelheim
NCT06335303: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Not yet recruiting
2
300
NA
BI 1819479, Placebo matching BI 1819479
Boehringer Ingelheim
Idiopathic Pulmonary Fibrosis
05/26
07/26

Download Options